Status:
COMPLETED
A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
Lead Sponsor:
Sanwa Kagaku Kenkyusho Co., Ltd.
Conditions:
Diabetic Macular Edema
Eligibility:
All Genders
20-79 years
Phase:
PHASE1
PHASE2
Brief Summary
This study will evaluate the safety and efficacy of intravitreal implant of dexamethasone for the treatment of diabetic edema.
Eligibility Criteria
Inclusion
- Diabetic macular edema
- Criteria for visual acuity and macular thickness are met
Exclusion
- History of glaucoma
- Known steroid-responder
- Use of systemic steroids
- Use of Warfarin/Heparin
- Other protocol-defined exclusion criteria may apply
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00308542
Last Update
February 13 2012
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Aichi, Japan
2
Chiba, Japan
3
Fukuoka, Japan
4
Gunma, Japan